Abstract
The rostral ventromedial medulla (RVM) has long been recognized to play a pivotal role in nociceptive modulation. Pro-nociception within the RVM is associated with a distinct functional class of neurons, ON-cells that begin to discharge immediately before nocifensive reflexes. Anti-nociceptive function within the RVM, including the analgesic response to opiates, is associated with another distinct class, OFF-cells, which pause immediately prior to nocifensive reflexes. A third class of RVM neurons, NEUTRAL-cells, does not alter firing in association with nocifensive reflexes. ON-, OFF- and NEUTRAL-cells show differential responsiveness to various behaviorally relevant neuromodulators, including purinergic ligands. Iontophoresis of semi-selective P2X ligands, which are associated with nociceptive transmission in the spinal cord and dorsal root ganglia, preferentially activate ON-cells. By contrast, P2Y ligands activate OFF-cells and P1 ligands suppress the firing of NEUTRAL cells. The current study investigates the distribution of P2X, P2Y and P1 receptor immunoreactivity in RVM neurons of Sprague-Dawley rats. Co-localization with tryptophan hydroxylase (TPH), a well-established marker for serotonergic neurons was also studied. Immunoreactivity for the four purinergic receptor subtypes examined was abundant in all anatomical subdivisions of the RVM. By contrast, TPH-immunoreactivity was restricted to a relatively small subset of RVM neurons concentrated in the nucleus raphe magnus and pallidus, as expected. There was a significant degree of co-localization of each purinergic receptor subtype with TPH-immunoreactivity. This co-localization was most pronounced for P2Y1 receptor immunoreactivity, although this was the least abundant among the different purinergic receptor subtypes examined. Immunoreactivity for multiple purinergic receptor subtypes was often co-localized in single neurons. These results confirm the physiological finding that purinergic receptors are widely expressed in the RVM. Purinergic neurotransmission in this region may play an important role in nociception and/or nociceptive modulation, as at other levels of the neuraxis.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 915-921 |
| Number of pages | 7 |
| Journal | Neuroscience |
| Volume | 158 |
| Issue number | 2 |
| DOIs | |
| State | Published - Jan 23 2009 |
Funding
We thank Andrew J. Lawrence for the kind donation of purinergic antibodies, Shirley McCartney, PhD for professional manuscript preparation, Andy Rekito, MS for figure preparation, and Kim J. Burchiel, MD for support of the Department of Neurological Surgery Laboratories at OHSU and personal encouragement. Supported by grants from the NIH (NS44255, N.R.S. and DA05608, M.M.H.) and the Cameron Foundation.
| Funders | Funder number |
|---|---|
| Author National Institutes of Health National Institutes of Health National Institutes of Health National Institutes of Health The Bev Hartig Huntington's Disease Foundation National Institutes of Health | DA05608 |
| National Institute of Neurological Disorders and Stroke | K08NS044255 |
Keywords
- RVM
- immunohistochemistry
- nociception
- purinergic receptors
ASJC Scopus subject areas
- General Neuroscience
Fingerprint
Dive into the research topics of 'Purinergic receptor immunoreactivity in the rostral ventromedial medulla'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS